Twist Bioscience
TWST
236 hedge funds and large institutions have $3.96B invested in Twist Bioscience in 2021 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 81 increasing their positions, 74 reducing their positions, and 42 closing their positions.
106% more capital inflows, than outflows
Capital inflows: $468M | Capital outflows: $227M
4.53% more ownership
Funds ownership: 98.72% → 103.25% (+4.5%)
9% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 74
0% less funds holding
Funds holding: 237 → 236 (-1)
26% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 42
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
46% less call options, than puts
Call options by funds: $8.03M | Put options by funds: $14.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
+$71.8M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$42M |
| 3 |
BlackRock
New York
|
+$32.4M |
| 4 |
Millennium Management
New York
|
+$30.9M |
| 5 |
Jackson Square Partners
Larkspur,
California
|
+$26.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Casdin Capital
New York
|
-$33.9M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$27.9M |
| 3 |
ARK Investment Management
St. Petersburg,
Florida
|
-$18.4M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$17.4M |
| 5 |
Blue Water Life Science Advisors
Larkspur,
California
|
-$13.4M |
TWST Hedge Fund Activity: Q4 2021 in Review
236 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2021, worth a combined $3.96B — down 24% from $5.2B a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of TWST and 31 opened new positions — a net loss of 11 holders — while 74 trimmed existing stakes and 81 added.
The largest buyer was Ardevora Asset Management, opening a new position worth an estimated $71.8M. The largest seller was Casdin Capital, cutting an estimated $33.9M.
- 236 institutional investors held Twist Bioscience (TWST) as of Q4 2021, down from 237 in Q3 2021.
- Funds reported $3.96B of Twist Bioscience stock for Q4 2021, down 24% quarter-over-quarter.
- 31 funds opened new Twist Bioscience positions in Q4 2021 and 42 closed out, a net change of -11 holders.
- The largest Twist Bioscience buyer in Q4 2021 was Ardevora Asset Management, an estimated $71.8M added.
- The largest Twist Bioscience seller in Q4 2021 was Casdin Capital, an estimated $33.9M sold.
Based on aggregated 13F filings for Q4 2021.